Browsing Tag
S&P Global Ratings
5 posts
Munich Re (ETR: MUV2) trades 23% below 52-week high as reinsurance pricing softens into hurricane season
Munich Re beat Q1 by 57% and reaffirmed €6.3bn guidance. The stock is down 23%. The real question is whether softening renewal prices break the Ambition 2030 thesis.
Infratil (ASX: IFT) shares jump 11.7% on CDC’s record 555MW data centre deal
Hyperscalers are running out of US power. CDC just signed Australia's biggest ever data centre contract. Infratil holders now own the build.
Hut 8 (NASDAQ: HUT) stock faces AI infrastructure test as $3.25bn notes plan funds River Bend data center
Hut 8 wants AI infrastructure scale without equity dilution. Its $3.25B debt plan now tests whether River Bend can deliver.
Inside Galderma’s €500m bond deal and what it reveals about the dermatology market’s financial momentum
Galderma raises €500M via a five-year eurobond to refinance IPO debt and strengthen its balance sheet. Discover what this means for GALD investors.
Thermo Fisher raises $2.5bn in bonds—But what’s the bigger play behind the debt move?
Thermo Fisher Scientific priced $2.5B in senior notes to fuel acquisitions, refinancing, and growth. See how the deal shapes TMO’s 2026 outlook.